Gender dimorphisms exist in the pathogenesis of a variety of cardiovascular,
cardiopulmonary, neurodegenerative, and endocrine disorders. Estrogens exert immense …

Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

The yearly incidence of the acute myeloblastic leukaemias (AMLs) in European adults is 5–8
cases per 100 000 individuals, and in myelodysplastic syndromes (MDSs) 4–5 new …

Awong G. et al.(2009). Characterization in vitro and engraftment potential in vivo of human
progenitor T cells generated from hematopoietic stem cells. Blood 114 (5): 972-982. Beq S …

Acute myeloid leukaemia (AML) secondary to myelodysplastic syndrome (MDS) is
characterized by poor prognosis, namely in older patients. The combination of fludarabine …

Hematopoietic stem cell transplantation is used to treat a wide pathologic spectrum and is
preceded by conditioning chemoradiation. The recipient's immune system changes …

As síndromes mielodisplásicas (SMD) constituem um grupo de doenças hematológicas
caracterizadas por citopenias crônicas, associadas a uma maturação celular anormal. A …

Allogeneic stem cell transplantation (SCT) is the only therapeutic modality at present that
may be delivered with curative intent in patients with myelodysplastic syndromes (MDS) …

The transcription factor, early B cell factor 1 (EBF1), plays a vital role in the lineage
specification involving early B cell development and the onset of myelodysplastic syndrome …

Myelodysplastic syndromes (MDS) are very heterogeneous diseases in terms of clinical
presentation and prognosis. Patients with pure red cell dysplasias have a life expectancy of …